Doctors track Real-Life use of new heart failure pill

NCT ID NCT06336330

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how the drug dapagliflozin is used for heart failure in real-world medical settings in Germany. It will observe 765 patients who have recently started taking the drug to see how long they stay on it, if their symptoms and quality of life improve, and how the treatment affects their daily activities and work. The goal is to gather practical information about the drug's use outside of controlled clinical trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Aachen, 52062, Germany
Research Site

Alsfeld, 36304, Germany
Research Site

Bamberg, 96049, Germany
Research Site

Bechhofen, 66894, Germany
Research Site

Bergisch Gladbach, 51465, Germany
Research Site

Berlin, 12489, Germany
Research Site

Berlin, 12555, Germany
Research Site

Brilon, 59929, Germany
Research Site

Bruchsal, 76646, Germany
Research Site

Chemnitz, 09113, Germany
Research Site

Dinslaken, 46535, Germany
Research Site

Erfurt, 99084, Germany
Research Site

Erfurt, 99097, Germany
Research Site

Essen, 45128, Germany
Research Site

Frankenthal, 67227, Germany
Research Site

Gera, 07551, Germany
Research Site

Hamburg, 20095, Germany
Research Site

Hamburg, 22087, Germany
Research Site

Hamburg, 22459, Germany
Research Site

Hoppegarten, 15366, Germany
Research Site

Kaiserslautern, 67655, Germany
Research Site

Kitzingen, 97318, Germany
Research Site

Ludwigsburg, 71634, Germany
Research Site

Ludwigshafen am Rhein, 67071, Germany
Research Site

M Hldorf, 84453, Germany
Research Site

Markkleeberg, 4416, Germany
Research Site

Meiningen, 98617, Germany
Research Site

Münster, 48149, Germany
Research Site

Naumburg, 6618, Germany
Research Site

Nuremberg, 90402, Germany
Research Site

Oschersleben, 39387, Germany
Research Site

Papenburg, 26871, Germany
Research Site

Pirna, 01796, Germany
Research Site

Potsdam, 14471, Germany
Research Site

Querfurt, 06268, Germany
Research Site

Ratingen, 40882, Germany
Research Site

Rostock, 18059, Germany
Research Site

Schleswig, 24837, Germany
Research Site

Schwandorf in Bayern, 92421, Germany
Research Site

Schwäbisch Hall, 74523, Germany
Research Site

Siegen, 57072, Germany
Research Site

Steinfurt, 48565, Germany
Research Site

Stollberg, 09366, Germany
Research Site

Straubing, 94315, Germany
Research Site

Stuttgart, 70178, Germany
Research Site

Ulm, 89073, Germany
Research Site

Wermsdorf, 04779, Germany

Conditions

Explore the condition pages connected to this study.

CARDIOVASCULAR DISEASES HEART DISEASES HEART FAILURE